NASDAQ:RGLS   Regulus Therapeutics Inc.
RGLS .. We are in full phase two COVID-19. There are many aspects and many pharmaceutical companies that are trying to shine, especially in the research and experimentation of drugs of all kinds ... Let's add that a Master of Biotech finance like Steven Cohen buys 8.5% of shares (5.6 million shares). ..
Remember what happened to COCP when Cohen himself bought 2.5% of shares (2.5 million shares) and went from 0.8 to 2.5 in a week ... so beware so maximum long alert ..
I make you a super Christmas gift in advance. Happy trading everyone.
Comment:
PLS follower ..attention hereeeeeeee

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.